MQii Blog: GLP-1s and Quality Obesity and Nutritional Care
GLP-1s and Quality Obesity and Nutritional Care The use of GLP-1 receptor agonists—such as semaglutide and tirzepatide—has surged in recent years, transforming the landscape of obesity and diabetes management. According to the Centers for Disease Control and Prevention (CDC), “in 2024, 26.5% of adults with diagnosed diabetes used GLP-1 injectables to lower blood sugar or […]